Suppr超能文献

RU-26988——一种用于研究盐皮质激素受体的新工具。

RU-26988--a new tool for the study of the mineralocorticoid receptor.

作者信息

Gomez-Sanchez C E, Gomez-Sanchez E P

出版信息

Endocrinology. 1983 Sep;113(3):1004-9. doi: 10.1210/endo-113-3-1004.

Abstract

Aldosterone binds to two renal cytosol receptors, one with high affinity and low capacity (Type I or mineralocorticoid) and another with lower affinity but greater capacity (Type II or glucocorticoid receptor). One of the ways to study Type I receptors isolated from Type II receptors is to block the latter with a steroid which shows high affinity for the glucocorticoid receptor and low affinity for the mineralocorticoid receptor. Dexamethasone has been used widely for this purpose but previous investigations and this study have found that dexamethasone competes with [3H]aldosterone for Type I receptor binding with a relative activity of 26% that of aldosterone and therefore is less than ideal as a glucocorticoid receptor blocker. RU-26988 (11 beta, 17 beta-dihydroxy-17 alpha-pregnane-1,4,6-trien-20-yn-21-methyl-3-one) is a recently synthesized glucocorticoid that shows very low affinity for the mineralocorticoid receptor. RU-26988 competes with [3H]aldosterone and [3H]2 alpha-methyl-9 alpha-fluorocortisol, a powerful mineralocorticoid, for the cytosol receptor from renal slices of adrenalectomized rats with a relative potency of less than 0.5% in comparison to unlabeled aldosterone and 2 alpha-methyl-9 alpha-fluorocortisol. RU-26988 has over twice the ability of unlabeled dexamethasone to compete with [3H]dexamethasone for binding to the renal cytosol glucocorticoid receptor. Scatchard analysis of [3H]aldosterone binding to rat renal cytosol showed two receptors, one with a calculated dissociation constant (Kd) of 2.81 X 10(-9) M and a second with a calculated Kd of 3.33 X 10(-8) M. The addition of a 100-fold concentration of RU-26988 produced a single line with a Kd of 5.02 X 10(-10) M indicating that the specific blocking of the glucocorticoid receptors allows an accurate determination of the kinetic parameters of the mineralocorticoid receptor by itself. Scatchard analysis of [3H]2 alpha-methyl-9 alpha-fluorocortisol binding produced a straight line with a Kd of 3.7 X 10(-9) M, such as would be produced if it were binding to only one single class of receptors. However, when an excess of RU-26988 was added to block the glucocorticoid receptor, a different straight line was produced by Scatchard's analysis with a Kd of 3.78 X 10(-10) M. Whereas the explanation for this is not apparent, it may be that the much larger concentration of glucocorticoid receptors, for which 2 alpha-methyl-9 alpha-fluorocortisol also has a very great affinity, masks the binding to the mineralocorticoid receptors.

摘要

醛固酮与两种肾细胞溶质受体结合,一种具有高亲和力和低容量(I型或盐皮质激素受体),另一种具有较低亲和力但容量较大(II型或糖皮质激素受体)。从II型受体中分离出I型受体的一种方法是用一种对糖皮质激素受体具有高亲和力而对盐皮质激素受体具有低亲和力的类固醇来阻断后者。地塞米松已被广泛用于此目的,但先前的研究和本研究发现,地塞米松与[3H]醛固酮竞争I型受体结合,其相对活性为醛固酮的26%,因此作为糖皮质激素受体阻滞剂不太理想。RU - 26988(11β,17β - 二羟基 - 17α - 孕烷 - 1,4,6 - 三烯 - 20 - 炔 - 21 - 甲基 - 3 - 酮)是一种最近合成的糖皮质激素,对盐皮质激素受体显示出非常低的亲和力。RU - 26988与[3H]醛固酮和[3H]2α - 甲基 - 9α - 氟皮质醇(一种强效盐皮质激素)竞争去肾上腺大鼠肾切片的细胞溶质受体,与未标记的醛固酮和2α - 甲基 - 9α - 氟皮质醇相比,其相对效力小于0.5%。RU - 26988与未标记的地塞米松相比,与[3H]地塞米松竞争结合肾细胞溶质糖皮质激素受体的能力高出两倍多。对[3H]醛固酮与大鼠肾细胞溶质结合的Scatchard分析显示有两种受体,一种计算出的解离常数(Kd)为2.81×10^(-9) M,另一种计算出的Kd为3.33×10^(-8) M。加入100倍浓度的RU - 26988产生一条Kd为5.02×10^(-10) M的单一曲线,表明糖皮质激素受体的特异性阻断使得能够准确测定盐皮质激素受体自身的动力学参数。对[3H]2α - 甲基 - 9α - 氟皮质醇结合的Scatchard分析产生一条Kd为3.7×10^(-9) M的直线,就好像它只与一类单一受体结合一样。然而,当加入过量的RU - 26988来阻断糖皮质激素受体时,Scatchard分析产生了一条不同的直线,Kd为3.78×10^(-10) M。虽然对此的解释尚不清楚,但可能是糖皮质激素受体的浓度大得多,而2α - 甲基 - 9α - 氟皮质醇对其也有非常高的亲和力,掩盖了与盐皮质激素受体的结合。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验